Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Other Working Capital Changes (2023 - 2025)

Cannabis Bioscience International Holdings' Other Working Capital Changes history spans 3 years, with the latest figure at -$14111.0 for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes fell 205.76% to -$14111.0 in Q4 2025 year-over-year; TTM through Feb 2026 was -$10143.0, a 26.74% increase, with the full-year FY2025 number at -$21877.0, up 23.62% from a year prior.
  • Other Working Capital Changes hit -$14111.0 in Q4 2025 for Cannabis Bioscience International Holdings, down from $12000.0 in the prior quarter.
  • Over the last five years, Other Working Capital Changes for CBIH hit a ceiling of $12000.0 in Q3 2025 and a floor of -$43423.0 in Q2 2023.
  • Historically, Other Working Capital Changes has averaged -$10672.4 across 3 years, with a median of -$8032.0 in 2025.
  • The widest YoY moves for Other Working Capital Changes: up 363.27% in 2025, down 205.76% in 2025.
  • Tracing CBIH's Other Working Capital Changes over 3 years: stood at -$20308.0 in 2023, then skyrocketed by 77.27% to -$4615.0 in 2024, then tumbled by 205.76% to -$14111.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for CBIH at -$14111.0 in Q4 2025, $12000.0 in Q3 2025, and -$8032.0 in Q2 2025.